Rangering i aksjer
#27692
CapForce Inc. is a precision medicine company dedicated to developing and... CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.
Aksjekurs
$2.97
Sist synkronisert: 2026-08-19
Endring (1 år)
2,969,900.09%
Handel CapForce Inc. (CFOR)
Pris CFOR pris med markedsverdi på B
Markedsverdi av CapForce Inc.(CFOR)
Markedsverdi: $31.23M
Per August 2026 har CapForce Inc. en markedsverdi på $31.23M. Dette gjør CapForce Inc. til det 27692nd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for CapForce Inc. fra 2015 til 2026
CFOR sammenlignet med topp 5 mest populære stocks
| Pris på CFOR |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.301T
|
+16,972,167.74%
|
|
|
|
|
$4.634T
|
+14,836,573.93%
|
|
|
|
|
$4.143T
|
+13,264,855.74%
|
|
|
|
|
$3.589T
|
+11,492,318.91%
|
|
|
|
|
$2.857T
|
+9,147,250.45%
|
